By Fineline Cube 
Sainte Nutritional Inc., China’s leading provider of Food for Special Medical Purpose (FSMP), has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. CITIC Securities is acting as the sole sponsor for the filing.
FSMP Products and Approvals
Sainte Nutritional was the first company in China to gain approval for FSMP products in 2011. It has received marketing approvals for two metabolic disorder products: Teai Bingjia, the sole FSMP product in China for infants with propionic acidemia or methylmalonic acidemia, and Teai Benjia, the first locally developed FSMP for infants with phenylketonuria (PKU).
Product Portfolio and Growth
The company currently offers a portfolio of 14 FSMP products with an additional 16 in development. In 2024, Sainte Nutritional generated RMB 834 million (USD 116 million) in revenue.-Fineline Info & Tech